Annual Income Statements for Cushman & Wakefield
This table shows Cushman & Wakefield's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Cushman & Wakefield
This table shows Cushman & Wakefield's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
| Metric |
|
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
| Net Income / (Loss) Attributable to Common Shareholders |
|
-34 |
70 |
-29 |
14 |
34 |
113 |
1.90 |
57 |
51 |
-22 |
-13 |
| Consolidated Net Income / (Loss) |
|
-34 |
70 |
-29 |
14 |
34 |
113 |
1.90 |
57 |
51 |
-22 |
-13 |
| Net Income / (Loss) Continuing Operations |
|
-34 |
70 |
-29 |
14 |
34 |
113 |
1.90 |
57 |
51 |
-22 |
-13 |
| Total Pre-Tax Income |
|
-17 |
70 |
-27 |
17 |
53 |
132 |
5.00 |
76 |
45 |
-12 |
-9.60 |
| Total Revenue |
|
2,213 |
2,512 |
2,138 |
2,232 |
2,301 |
2,583 |
2,243 |
2,431 |
2,541 |
2,688 |
2,483 |
| Net Interest Income / (Expense) |
|
-90 |
-57 |
-59 |
-61 |
-55 |
-56 |
-52 |
-53 |
-56 |
-55 |
-49 |
| Total Interest Income |
|
0.00 |
-281 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Total Interest Expense |
|
90 |
-224 |
59 |
61 |
55 |
56 |
52 |
53 |
56 |
55 |
49 |
| Long-Term Debt Interest Expense |
|
90 |
- |
59 |
61 |
55 |
56 |
52 |
53 |
56 |
55 |
49 |
| Total Non-Interest Income |
|
2,303 |
2,569 |
2,197 |
2,292 |
2,356 |
2,639 |
2,296 |
2,484 |
2,597 |
2,743 |
2,532 |
| Net Realized & Unrealized Capital Gains on Investments |
|
17 |
17 |
12 |
4.30 |
12 |
9.30 |
11 |
0.20 |
-8.60 |
-171 |
-4.10 |
| Other Non-Interest Income |
|
2,286 |
2,552 |
2,185 |
2,288 |
2,344 |
2,630 |
2,285 |
2,484 |
2,606 |
2,914 |
2,536 |
| Total Non-Interest Expense |
|
2,228 |
2,444 |
2,166 |
2,218 |
2,269 |
2,481 |
2,239 |
2,361 |
2,498 |
2,737 |
2,477 |
| Other Operating Expenses |
|
2,183 |
2,391 |
2,129 |
2,169 |
2,226 |
2,421 |
2,206 |
2,335 |
2,473 |
2,712 |
2,452 |
| Depreciation Expense |
|
36 |
37 |
33 |
31 |
29 |
30 |
27 |
26 |
26 |
26 |
25 |
| Impairment Charge |
|
9.20 |
15 |
5.00 |
17 |
14 |
4.60 |
6.50 |
0.00 |
0.00 |
-0.40 |
0.00 |
| Nonoperating Income / (Expense), net |
|
-2.00 |
- |
1.70 |
3.30 |
21 |
- |
0.90 |
6.40 |
2.20 |
37 |
-15 |
| Income Tax Expense |
|
17 |
0.30 |
2.30 |
3.70 |
19 |
19 |
3.10 |
19 |
-6.30 |
10 |
3.00 |
| Basic Earnings per Share |
|
($0.15) |
$0.31 |
($0.13) |
$0.06 |
$0.15 |
$0.49 |
$0.01 |
$0.25 |
$0.22 |
($0.10) |
($0.05) |
| Weighted Average Basic Shares Outstanding |
|
227.20M |
226.90M |
227.90M |
229M |
229.30M |
228.90M |
230.40M |
231.40M |
231.50M |
231.20M |
232.80M |
| Diluted Earnings per Share |
|
($0.15) |
$0.31 |
($0.13) |
$0.06 |
$0.14 |
$0.49 |
$0.01 |
$0.25 |
$0.22 |
($0.10) |
($0.05) |
| Weighted Average Diluted Shares Outstanding |
|
227.20M |
226.90M |
227.90M |
231.50M |
233.40M |
232.80M |
232.30M |
232.40M |
235.90M |
234.70M |
232.80M |
| Weighted Average Basic & Diluted Shares Outstanding |
|
227.25M |
227.33M |
229.05M |
229.25M |
229.49M |
229.73M |
231.29M |
231.53M |
231.60M |
231.82M |
234.30M |
Annual Cash Flow Statements for Cushman & Wakefield
This table details how cash moves in and out of Cushman & Wakefield's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
| Metric |
|
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Net Change in Cash & Equivalents |
|
-116 |
29 |
506 |
-95 |
276 |
-266 |
-151 |
80 |
36 |
-31 |
| Net Cash From Operating Activities |
|
-335 |
4.40 |
-2.20 |
269 |
-38 |
550 |
49 |
152 |
208 |
340 |
| Net Cash From Continuing Operating Activities |
|
-335 |
4.40 |
-2.20 |
269 |
-38 |
550 |
49 |
152 |
208 |
340 |
| Net Income / (Loss) Continuing Operations |
|
-435 |
-221 |
-186 |
0.20 |
-221 |
250 |
196 |
-35 |
131 |
88 |
| Consolidated Net Income / (Loss) |
|
-435 |
-221 |
-186 |
0.20 |
-221 |
250 |
196 |
-35 |
131 |
88 |
| Provision For Loan Losses |
|
12 |
3.90 |
24 |
26 |
48 |
38 |
32 |
11 |
21 |
22 |
| Depreciation Expense |
|
261 |
271 |
290 |
297 |
264 |
172 |
147 |
146 |
122 |
104 |
| Amortization Expense |
|
13 |
17 |
13 |
122 |
128 |
114 |
112 |
105 |
94 |
95 |
| Non-Cash Adjustments to Reconcile Net Income |
|
38 |
42 |
138 |
49 |
-25 |
68 |
87 |
101 |
6.40 |
187 |
| Changes in Operating Assets and Liabilities, net |
|
-224 |
-107 |
-280 |
-226 |
-233 |
-92 |
-524 |
-175 |
-167 |
-156 |
| Net Cash From Investing Activities |
|
-138 |
-143 |
-218 |
-275 |
-258 |
-750 |
-121 |
49 |
81 |
-21 |
| Net Cash From Continuing Investing Activities |
|
-138 |
-143 |
-218 |
-275 |
-258 |
-750 |
-121 |
49 |
81 |
-21 |
| Purchase of Property, Leasehold Improvements and Equipment |
|
-77 |
-129 |
-84 |
-80 |
-41 |
-54 |
-51 |
-51 |
-41 |
-47 |
| Purchase of Investment Securities |
|
-57 |
-100 |
-49 |
-280 |
-123 |
-696 |
-139 |
-0.10 |
-0.40 |
-5.20 |
| Sale and/or Maturity of Investments |
|
3.80 |
86 |
-85 |
86 |
-94 |
0.20 |
69 |
100 |
123 |
32 |
| Net Cash From Financing Activities |
|
357 |
168 |
726 |
-90 |
572 |
-66 |
-79 |
-121 |
-253 |
-351 |
| Net Cash From Continuing Financing Activities |
|
357 |
168 |
726 |
-90 |
572 |
-66 |
-79 |
-121 |
-253 |
-351 |
| Issuance of Debt |
|
640 |
319 |
2,937 |
0.00 |
650 |
0.00 |
0.00 |
2,400 |
0.00 |
0.00 |
| Repayment of Debt |
|
-320 |
-164 |
-3,168 |
-39 |
-43 |
-40 |
-44 |
-2,470 |
-200 |
-300 |
| Other Financing Activities, Net |
|
-2.90 |
-11 |
-62 |
-51 |
-35 |
-26 |
-35 |
-51 |
-53 |
-51 |
Quarterly Cash Flow Statements for Cushman & Wakefield
This table details how cash moves in and out of Cushman & Wakefield's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
| Metric |
|
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
| Net Change in Cash & Equivalents |
|
71 |
157 |
-209 |
22 |
197 |
26 |
-183 |
-16 |
20 |
148 |
-178 |
| Net Cash From Operating Activities |
|
188 |
202 |
-125 |
22 |
196 |
115 |
-162 |
9.60 |
236 |
257 |
-244 |
| Net Cash From Continuing Operating Activities |
|
188 |
202 |
-125 |
22 |
196 |
115 |
-162 |
9.60 |
236 |
257 |
-244 |
| Net Income / (Loss) Continuing Operations |
|
-34 |
70 |
-29 |
14 |
34 |
113 |
1.90 |
57 |
51 |
-22 |
-13 |
| Consolidated Net Income / (Loss) |
|
-34 |
70 |
-29 |
14 |
34 |
113 |
1.90 |
57 |
51 |
-22 |
-13 |
| Provision For Loan Losses |
|
3.00 |
5.80 |
2.40 |
5.30 |
3.00 |
10 |
2.80 |
-0.20 |
5.50 |
14 |
4.80 |
| Depreciation Expense |
|
36 |
37 |
33 |
31 |
29 |
30 |
27 |
26 |
26 |
26 |
25 |
| Amortization Expense |
|
25 |
28 |
24 |
26 |
24 |
21 |
24 |
24 |
23 |
24 |
24 |
| Non-Cash Adjustments to Reconcile Net Income |
|
23 |
26 |
-6.80 |
9.50 |
-12 |
16 |
3.90 |
8.60 |
22 |
153 |
55 |
| Changes in Operating Assets and Liabilities, net |
|
135 |
36 |
-148 |
-63 |
118 |
-74 |
-221 |
-106 |
108 |
64 |
-341 |
| Net Cash From Investing Activities |
|
-65 |
-31 |
-11 |
68 |
57 |
-33 |
21 |
11 |
-60 |
7.90 |
94 |
| Net Cash From Continuing Investing Activities |
|
-65 |
-31 |
-11 |
68 |
57 |
-33 |
21 |
11 |
-60 |
7.90 |
94 |
| Purchase of Property, Leasehold Improvements and Equipment |
|
-14 |
-16 |
-11 |
-12 |
-9.40 |
-9.30 |
-4.60 |
-9.30 |
-11 |
-23 |
-12 |
| Purchase of Investment Securities |
|
41 |
4.90 |
-0.30 |
100 |
0.40 |
-506 |
-12 |
-0.20 |
-388 |
388 |
-1.10 |
| Sale and/or Maturity of Investments |
|
-92 |
-20 |
0.00 |
-20 |
-55 |
481 |
37 |
20 |
339 |
-357 |
107 |
| Net Cash From Financing Activities |
|
-52 |
-14 |
-73 |
-68 |
-57 |
-56 |
-41 |
-36 |
-156 |
-117 |
-28 |
| Net Cash From Continuing Financing Activities |
|
-52 |
-14 |
-73 |
-68 |
-57 |
-56 |
-41 |
-36 |
-156 |
-117 |
-28 |
| Repayment of Debt |
|
-1,431 |
-2.20 |
-55 |
-38 |
-50 |
-79 |
-25 |
-25 |
-170 |
-80 |
0.00 |
| Other Financing Activities, Net |
|
-21 |
-12 |
-18 |
-30 |
-7.00 |
23 |
-16 |
-11 |
14 |
-37 |
-28 |
Annual Balance Sheets for Cushman & Wakefield
This table presents Cushman & Wakefield's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Total Assets |
|
5,793 |
6,546 |
7,163 |
7,338 |
7,890 |
7,949 |
7,774 |
7,549 |
7,677 |
| Cash and Due from Banks |
|
406 |
895 |
813 |
1,075 |
771 |
645 |
768 |
793 |
784 |
| Trading Account Securities |
|
7.90 |
8.70 |
7.90 |
115 |
641 |
677 |
708 |
724 |
537 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Premises and Equipment, Net |
|
304 |
314 |
299 |
236 |
195 |
173 |
164 |
136 |
133 |
| Goodwill |
|
1,765 |
1,779 |
1,969 |
2,098 |
2,082 |
2,066 |
2,081 |
1,998 |
2,058 |
| Intangible Assets |
|
1,306 |
1,128 |
1,063 |
991 |
922 |
875 |
806 |
690 |
655 |
| Other Assets |
|
2,004 |
2,422 |
3,011 |
2,823 |
3,280 |
3,515 |
3,248 |
3,208 |
3,510 |
| Total Liabilities & Shareholders' Equity |
|
5,793 |
6,546 |
7,163 |
7,338 |
7,890 |
7,949 |
7,774 |
7,549 |
7,677 |
| Total Liabilities |
|
5,294 |
5,186 |
5,862 |
6,242 |
6,442 |
6,287 |
6,096 |
5,794 |
5,721 |
| Short-Term Debt |
|
60 |
40 |
39 |
40 |
42 |
50 |
150 |
103 |
125 |
| Accrued Interest Payable |
|
36 |
43 |
60 |
45 |
105 |
33 |
21 |
20 |
29 |
| Other Short-Term Payables |
|
1,870 |
1,956 |
2,224 |
1,981 |
2,287 |
2,308 |
2,227 |
2,207 |
2,438 |
| Long-Term Debt |
|
2,784 |
2,644 |
2,620 |
3,236 |
3,221 |
3,212 |
3,097 |
2,940 |
2,625 |
| Other Long-Term Liabilities |
|
544 |
503 |
919 |
941 |
787 |
685 |
602 |
524 |
504 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Equity & Noncontrolling Interests |
|
499 |
1,360 |
1,301 |
1,096 |
1,449 |
1,662 |
1,678 |
1,755 |
1,956 |
| Total Preferred & Common Equity |
|
499 |
1,360 |
1,301 |
1,095 |
1,448 |
1,661 |
1,677 |
1,755 |
1,955 |
| Total Common Equity |
|
499 |
1,360 |
1,301 |
1,095 |
1,448 |
1,661 |
1,677 |
1,755 |
1,955 |
| Common Stock |
|
1,735 |
2,813 |
2,819 |
2,866 |
2,919 |
2,934 |
2,980 |
3,009 |
3,062 |
| Retained Earnings |
|
-1,149 |
-1,298 |
-1,297 |
-1,528 |
-1,278 |
-1,082 |
-1,117 |
-986 |
-898 |
| Accumulated Other Comprehensive Income / (Loss) |
|
-87 |
-154 |
-243 |
-243 |
-193 |
-191 |
-185 |
-269 |
-209 |
| Noncontrolling Interest |
|
- |
- |
0.00 |
0.90 |
0.80 |
0.80 |
0.60 |
0.50 |
0.50 |
Quarterly Balance Sheets for Cushman & Wakefield
This table presents Cushman & Wakefield's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
Q3 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q1 2026 |
| Total Assets |
|
7,622 |
7,622 |
7,640 |
7,582 |
7,491 |
7,343 |
7,534 |
7,408 |
7,555 |
7,691 |
7,648 |
| Cash and Due from Banks |
|
381 |
460 |
502 |
588 |
554 |
567 |
775 |
623 |
618 |
634 |
601 |
| Trading Account Securities |
|
659 |
686 |
682 |
694 |
714 |
711 |
724 |
735 |
732 |
720 |
529 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Premises and Equipment, Net |
|
156 |
170 |
166 |
160 |
155 |
148 |
142 |
126 |
124 |
122 |
134 |
| Goodwill |
|
2,021 |
2,067 |
2,073 |
2,052 |
2,064 |
2,024 |
2,049 |
2,021 |
2,060 |
2,055 |
2,059 |
| Intangible Assets |
|
885 |
858 |
841 |
823 |
791 |
712 |
703 |
682 |
675 |
664 |
645 |
| Other Assets |
|
3,519 |
3,382 |
3,376 |
3,265 |
3,213 |
3,181 |
3,141 |
3,220 |
3,347 |
3,496 |
3,680 |
| Total Liabilities & Shareholders' Equity |
|
7,622 |
7,622 |
7,640 |
7,582 |
7,491 |
7,343 |
7,534 |
7,408 |
7,555 |
7,691 |
7,648 |
| Total Liabilities |
|
6,044 |
6,042 |
6,018 |
6,011 |
5,866 |
5,704 |
5,831 |
5,631 |
5,651 |
5,733 |
5,695 |
| Short-Term Debt |
|
46 |
34 |
37 |
119 |
125 |
142 |
96 |
109 |
175 |
129 |
130 |
| Accrued Interest Payable |
|
27 |
6.90 |
55 |
7.00 |
20 |
28 |
31 |
31 |
64 |
75 |
87 |
| Other Short-Term Payables |
|
2,150 |
2,080 |
2,031 |
2,091 |
2,035 |
1,966 |
2,114 |
2,063 |
2,087 |
2,302 |
2,210 |
| Long-Term Debt |
|
3,212 |
3,228 |
3,226 |
3,125 |
3,066 |
3,002 |
2,997 |
2,911 |
2,820 |
2,720 |
2,621 |
| Other Long-Term Liabilities |
|
609 |
694 |
668 |
669 |
620 |
567 |
593 |
517 |
505 |
507 |
648 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Equity & Noncontrolling Interests |
|
1,578 |
1,580 |
1,622 |
1,572 |
1,625 |
1,640 |
1,703 |
1,777 |
1,904 |
1,958 |
1,953 |
| Total Preferred & Common Equity |
|
1,577 |
1,579 |
1,621 |
1,571 |
1,625 |
1,639 |
1,702 |
1,776 |
1,904 |
1,958 |
1,952 |
| Total Common Equity |
|
1,577 |
1,579 |
1,621 |
1,571 |
1,625 |
1,639 |
1,702 |
1,776 |
1,904 |
1,958 |
1,952 |
| Common Stock |
|
2,924 |
2,939 |
2,953 |
2,967 |
2,978 |
2,982 |
2,994 |
3,015 |
3,029 |
3,044 |
3,057 |
| Retained Earnings |
|
-1,112 |
-1,158 |
-1,153 |
-1,187 |
-1,146 |
-1,133 |
-1,099 |
-984 |
-927 |
-875 |
-910 |
| Accumulated Other Comprehensive Income / (Loss) |
|
-235 |
-202 |
-178 |
-209 |
-207 |
-211 |
-192 |
-255 |
-199 |
-211 |
-194 |
| Noncontrolling Interest |
|
0.70 |
0.50 |
0.60 |
0.50 |
0.60 |
0.60 |
0.60 |
0.50 |
0.60 |
0.50 |
0.40 |
Annual Metrics And Ratios for Cushman & Wakefield
This table displays calculated financial ratios and metrics derived from Cushman & Wakefield's official financial filings.
| Metric |
|
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
($1.09) |
$0.00 |
($1.00) |
$1.12 |
$0.87 |
($0.16) |
$0.57 |
$0.38 |
| Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
216.60M |
219.89M |
222.18M |
223M |
225.40M |
226.90M |
228.90M |
231.20M |
| Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
($1.09) |
$0.00 |
($1.00) |
$1.10 |
$0.86 |
($0.16) |
$0.56 |
$0.38 |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
216.60M |
224.50M |
220.80M |
226.50M |
228M |
226.90M |
232.80M |
234.70M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
($1.09) |
$0.00 |
($1.00) |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
171.20M |
217.70M |
220.80M |
224.55M |
225.80M |
227.33M |
229.73M |
231.82M |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Quarterly Metrics And Ratios for Cushman & Wakefield
This table displays calculated financial ratios and metrics derived from Cushman & Wakefield's official financial filings.
| Metric |
|
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
| DEI Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
231,821,697.00 |
| DEI Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
231,821,697.00 |
| DEI Earnings Per Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
-0.05 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Revenue Growth |
|
7,379.93% |
-67.59% |
-2.13% |
-5.48% |
3.99% |
2.83% |
4.94% |
8.94% |
10.42% |
- |
10.66% |
| EBITDA Growth |
|
-67.33% |
102.44% |
215.23% |
9.14% |
131.37% |
15.14% |
96.04% |
69.31% |
7.36% |
- |
0.73% |
| EBIT Growth |
|
-118.73% |
9,828.57% |
70.29% |
168.75% |
446.41% |
50.81% |
114.54% |
402.16% |
32.41% |
- |
31.71% |
| NOPAT Growth |
|
-127.48% |
134.23% |
70.29% |
164.71% |
414.66% |
61.75% |
107.89% |
381.10% |
137.33% |
- |
142.62% |
| Net Income Growth |
|
-241.84% |
134.23% |
62.30% |
164.71% |
199.41% |
61.75% |
106.60% |
324.44% |
52.52% |
- |
-763.16% |
| EPS Growth |
|
-236.36% |
158.33% |
61.76% |
200.00% |
193.33% |
58.06% |
107.69% |
316.67% |
57.14% |
- |
-600.00% |
| Operating Cash Flow Growth |
|
263.83% |
-16.95% |
43.52% |
229.76% |
4.25% |
-43.08% |
-29.50% |
-55.96% |
20.09% |
- |
-50.31% |
| Free Cash Flow Firm Growth |
|
103.27% |
137.74% |
105.99% |
413.55% |
445.92% |
247.82% |
325.54% |
-156.50% |
-4.54% |
- |
338.02% |
| Invested Capital Growth |
|
-0.42% |
0.02% |
-0.51% |
-2.09% |
-0.40% |
-2.57% |
-0.42% |
2.43% |
0.23% |
- |
-1.93% |
| Revenue Q/Q Growth |
|
-6.26% |
13.52% |
-55.45% |
4.38% |
3.13% |
12.25% |
-13.16% |
8.36% |
4.54% |
- |
-7.65% |
| EBITDA Q/Q Growth |
|
-32.30% |
189.32% |
-77.79% |
150.85% |
43.51% |
43.97% |
-64.36% |
119.63% |
-23.22% |
- |
9,050.00% |
| EBIT Q/Q Growth |
|
-339.06% |
545.10% |
-138.91% |
164.91% |
208.14% |
93.77% |
-96.01% |
1,602.44% |
-38.54% |
- |
111.07% |
| NOPAT Q/Q Growth |
|
-310.00% |
751.73% |
-126.58% |
172.78% |
149.63% |
235.01% |
-98.62% |
3,268.90% |
-6.85% |
- |
111.07% |
| Net Income Q/Q Growth |
|
-764.71% |
305.90% |
-141.26% |
146.88% |
149.63% |
235.01% |
-98.32% |
2,915.79% |
-10.30% |
- |
43.75% |
| EPS Q/Q Growth |
|
-850.00% |
306.67% |
-141.94% |
146.15% |
133.33% |
250.00% |
-97.96% |
2,400.00% |
-12.00% |
- |
50.00% |
| Operating Cash Flow Q/Q Growth |
|
1,219.64% |
7.60% |
-161.81% |
117.43% |
799.54% |
-41.25% |
-240.63% |
105.93% |
2,353.13% |
- |
-194.64% |
| Free Cash Flow Firm Q/Q Growth |
|
126.26% |
610.01% |
-90.77% |
1,722.05% |
-54.28% |
352.36% |
-90.82% |
-391.07% |
159.44% |
- |
64.58% |
| Invested Capital Q/Q Growth |
|
-1.42% |
2.26% |
-2.20% |
-0.69% |
0.28% |
0.04% |
-0.05% |
2.16% |
-1.88% |
- |
-0.04% |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBITDA Margin |
|
2.07% |
5.29% |
1.38% |
3.32% |
4.61% |
5.92% |
2.43% |
4.92% |
3.62% |
- |
2.21% |
| EBIT Margin |
|
-0.69% |
2.71% |
-1.24% |
0.77% |
2.30% |
3.98% |
0.18% |
2.87% |
1.69% |
- |
0.22% |
| Profit (Net Income) Margin |
|
-1.53% |
2.78% |
-1.35% |
0.61% |
1.46% |
4.37% |
0.08% |
2.36% |
2.02% |
- |
-0.51% |
| Tax Burden Percent |
|
195.95% |
99.57% |
108.68% |
78.49% |
63.58% |
85.47% |
38.00% |
75.20% |
113.97% |
- |
131.25% |
| Interest Burden Percent |
|
113.07% |
102.94% |
100.00% |
100.00% |
100.00% |
128.63% |
121.95% |
109.17% |
105.13% |
- |
-177.78% |
| Effective Tax Rate |
|
0.00% |
0.43% |
0.00% |
21.51% |
36.42% |
14.53% |
62.00% |
24.80% |
-13.97% |
- |
0.00% |
| Return on Invested Capital (ROIC) |
|
-1.46% |
5.23% |
-1.66% |
1.14% |
2.80% |
8.32% |
0.14% |
4.26% |
3.93% |
- |
0.33% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
|
-2.17% |
5.23% |
-1.98% |
1.14% |
2.80% |
8.32% |
0.15% |
4.42% |
4.01% |
- |
-0.24% |
| Return on Net Nonoperating Assets (RNNOA) |
|
-4.48% |
10.19% |
-3.98% |
2.24% |
5.42% |
15.24% |
0.27% |
7.66% |
6.51% |
- |
-0.38% |
| Return on Equity (ROE) |
|
-5.93% |
15.42% |
-5.63% |
3.37% |
8.21% |
23.56% |
0.40% |
11.92% |
10.44% |
- |
-0.05% |
| Cash Return on Invested Capital (CROIC) |
|
0.26% |
-0.45% |
0.77% |
2.54% |
2.23% |
4.85% |
3.33% |
1.34% |
4.19% |
- |
3.03% |
| Operating Return on Assets (OROA) |
|
-1.32% |
3.20% |
-1.51% |
0.94% |
2.80% |
4.80% |
0.23% |
3.68% |
2.17% |
- |
0.29% |
| Return on Assets (ROA) |
|
-2.92% |
3.28% |
-1.64% |
0.73% |
1.78% |
5.28% |
0.11% |
3.02% |
2.60% |
- |
-0.68% |
| Return on Common Equity (ROCE) |
|
-5.93% |
15.42% |
-5.63% |
3.37% |
8.21% |
23.55% |
0.40% |
11.92% |
10.43% |
- |
-0.05% |
| Return on Equity Simple (ROE_SIMPLE) |
|
-4.80% |
0.00% |
0.75% |
1.26% |
5.18% |
0.00% |
9.12% |
10.81% |
11.42% |
- |
3.78% |
| Net Operating Profit after Tax (NOPAT) |
|
-11 |
70 |
-19 |
14 |
34 |
113 |
1.56 |
52 |
49 |
- |
3.78 |
| NOPAT Margin |
|
-0.48% |
2.78% |
-0.87% |
0.61% |
1.46% |
4.37% |
0.07% |
2.16% |
1.92% |
- |
0.15% |
| Net Nonoperating Expense Percent (NNEP) |
|
0.71% |
0.00% |
0.32% |
0.00% |
0.00% |
0.00% |
-0.01% |
-0.16% |
-0.08% |
- |
0.57% |
| SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
| Operating Expenses to Revenue |
|
100.69% |
97.29% |
101.24% |
99.23% |
97.70% |
96.02% |
99.82% |
97.13% |
98.31% |
- |
99.78% |
| Earnings before Interest and Taxes (EBIT) |
|
-15 |
68 |
-27 |
17 |
53 |
103 |
4.10 |
70 |
43 |
- |
5.40 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
46 |
133 |
30 |
74 |
106 |
153 |
55 |
120 |
92 |
- |
55 |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Price to Book Value (P/BV) |
|
1.10 |
1.46 |
1.46 |
1.45 |
1.84 |
1.71 |
1.32 |
1.35 |
1.88 |
- |
1.46 |
| Price to Tangible Book Value (P/TBV) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Price to Revenue (P/Rev) |
|
0.12 |
0.26 |
0.26 |
0.26 |
0.34 |
0.32 |
0.25 |
0.27 |
0.38 |
- |
0.28 |
| Price to Earnings (P/E) |
|
0.00 |
0.00 |
194.84 |
115.64 |
35.43 |
22.86 |
14.49 |
12.44 |
16.49 |
- |
38.56 |
| Dividend Yield |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
| Earnings Yield |
|
0.00% |
0.00% |
0.51% |
0.86% |
2.82% |
4.37% |
6.90% |
8.04% |
6.06% |
- |
2.59% |
| Enterprise Value to Invested Capital (EV/IC) |
|
0.91 |
1.00 |
1.04 |
1.04 |
1.13 |
1.09 |
0.99 |
1.01 |
1.23 |
- |
1.06 |
| Enterprise Value to Revenue (EV/Rev) |
|
0.30 |
0.53 |
0.54 |
0.55 |
0.59 |
0.57 |
0.51 |
0.52 |
0.60 |
- |
0.49 |
| Enterprise Value to EBITDA (EV/EBITDA) |
|
18.08 |
22.34 |
18.17 |
17.57 |
15.89 |
14.48 |
12.19 |
11.27 |
13.27 |
- |
18.69 |
| Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
0.00 |
153.37 |
114.00 |
48.69 |
35.87 |
26.55 |
21.05 |
24.08 |
- |
72.05 |
| Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
0.00 |
411.07 |
240.72 |
61.72 |
48.03 |
33.97 |
27.24 |
27.84 |
- |
97.36 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
|
22.67 |
32.42 |
20.17 |
17.27 |
18.44 |
25.25 |
27.73 |
31.08 |
29.76 |
- |
19.28 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
|
351.26 |
0.00 |
135.18 |
40.38 |
50.68 |
22.28 |
29.64 |
76.08 |
29.35 |
- |
34.75 |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Debt to Equity |
|
2.06 |
1.93 |
1.96 |
1.92 |
1.82 |
1.73 |
1.70 |
1.57 |
1.46 |
- |
1.41 |
| Long-Term Debt to Equity |
|
1.99 |
1.85 |
1.89 |
1.83 |
1.76 |
1.67 |
1.64 |
1.48 |
1.39 |
- |
1.34 |
| Financial Leverage |
|
2.06 |
1.95 |
2.01 |
1.96 |
1.94 |
1.83 |
1.83 |
1.73 |
1.62 |
- |
1.55 |
| Leverage Ratio |
|
4.83 |
4.71 |
4.72 |
4.59 |
4.62 |
4.46 |
4.38 |
4.20 |
4.16 |
- |
4.04 |
| Compound Leverage Factor |
|
5.46 |
4.85 |
4.72 |
4.59 |
4.62 |
5.74 |
5.34 |
4.59 |
4.37 |
- |
-7.18 |
| Debt to Total Capital |
|
67.37% |
65.93% |
66.25% |
65.72% |
64.49% |
63.42% |
62.95% |
61.14% |
59.27% |
- |
58.48% |
| Short-Term Debt to Total Capital |
|
2.47% |
3.04% |
2.60% |
2.96% |
2.01% |
2.15% |
2.26% |
3.57% |
2.69% |
- |
2.76% |
| Long-Term Debt to Total Capital |
|
64.90% |
62.89% |
63.66% |
62.76% |
62.48% |
61.26% |
60.69% |
57.57% |
56.58% |
- |
55.72% |
| Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
| Noncontrolling Interests to Total Capital |
|
0.01% |
0.01% |
0.01% |
0.01% |
0.01% |
0.01% |
0.01% |
0.01% |
0.01% |
- |
0.01% |
| Common Equity to Total Capital |
|
32.62% |
34.06% |
33.74% |
34.27% |
35.49% |
36.57% |
37.04% |
38.85% |
40.72% |
- |
41.51% |
| Debt to EBITDA |
|
13.37 |
14.70 |
11.56 |
11.14 |
9.03 |
8.39 |
7.75 |
6.83 |
6.41 |
- |
10.30 |
| Net Debt to EBITDA |
|
10.94 |
11.22 |
9.56 |
9.13 |
6.77 |
6.20 |
6.15 |
5.42 |
4.98 |
- |
8.05 |
| Long-Term Debt to EBITDA |
|
12.88 |
14.02 |
11.11 |
10.64 |
8.75 |
8.11 |
7.48 |
6.43 |
6.12 |
- |
9.81 |
| Debt to NOPAT |
|
-410.13 |
-154.60 |
261.55 |
152.59 |
35.07 |
27.83 |
21.62 |
16.52 |
13.44 |
- |
53.64 |
| Net Debt to NOPAT |
|
-335.76 |
-118.04 |
216.18 |
125.05 |
26.28 |
20.57 |
17.16 |
13.11 |
10.45 |
- |
41.93 |
| Long-Term Debt to NOPAT |
|
-395.09 |
-147.47 |
251.30 |
145.71 |
33.98 |
26.88 |
20.84 |
15.56 |
12.83 |
- |
51.11 |
| Noncontrolling Interest Sharing Ratio |
|
0.04% |
0.04% |
0.03% |
0.04% |
0.03% |
0.03% |
0.03% |
0.03% |
0.03% |
- |
0.02% |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
|
9.69 |
69 |
6.35 |
116 |
53 |
239 |
22 |
-64 |
38 |
- |
96 |
| Operating Cash Flow to CapEx |
|
1,324.65% |
1,249.38% |
-1,191.43% |
184.75% |
2,086.17% |
1,238.71% |
-3,521.74% |
103.23% |
2,242.86% |
- |
-1,995.90% |
| Free Cash Flow to Firm to Interest Expense |
|
0.11 |
0.00 |
0.11 |
1.90 |
0.96 |
4.31 |
0.42 |
-1.20 |
0.68 |
- |
1.95 |
| Operating Cash Flow to Interest Expense |
|
2.10 |
0.00 |
-2.13 |
0.36 |
3.57 |
2.08 |
-3.10 |
0.18 |
4.21 |
- |
-4.95 |
| Operating Cash Flow Less CapEx to Interest Expense |
|
1.94 |
0.00 |
-2.31 |
0.16 |
3.40 |
1.91 |
-3.19 |
0.01 |
4.02 |
- |
-5.20 |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Asset Turnover |
|
1.91 |
1.18 |
1.22 |
1.21 |
1.22 |
1.21 |
1.26 |
1.28 |
1.29 |
- |
1.35 |
| Fixed Asset Turnover |
|
91.72 |
55.12 |
56.80 |
57.89 |
60.83 |
61.73 |
66.59 |
70.29 |
74.49 |
- |
77.96 |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Invested Capital |
|
4,816 |
4,925 |
4,816 |
4,783 |
4,796 |
4,798 |
4,796 |
4,899 |
4,807 |
- |
4,704 |
| Invested Capital Turnover |
|
3.01 |
1.88 |
1.91 |
1.88 |
1.91 |
1.90 |
1.95 |
1.97 |
2.04 |
- |
2.14 |
| Increase / (Decrease) in Invested Capital |
|
-20 |
1.00 |
-25 |
-102 |
-19 |
-126 |
-20 |
116 |
11 |
- |
-92 |
| Enterprise Value (EV) |
|
4,387 |
4,934 |
5,015 |
4,959 |
5,443 |
5,252 |
4,744 |
4,938 |
5,901 |
- |
4,993 |
| Market Capitalization |
|
1,731 |
2,454 |
2,377 |
2,382 |
3,125 |
3,002 |
2,348 |
2,560 |
3,686 |
- |
2,842 |
| Book Value per Share |
|
$6.92 |
$7.38 |
$7.13 |
$7.16 |
$7.43 |
$7.65 |
$7.73 |
$8.23 |
$8.45 |
- |
$8.42 |
| Tangible Book Value per Share |
|
($5.74) |
($5.32) |
($5.40) |
($4.79) |
($4.58) |
($4.07) |
($4.03) |
($3.59) |
($3.29) |
- |
($3.24) |
| Total Capital |
|
4,816 |
4,925 |
4,816 |
4,783 |
4,796 |
4,798 |
4,796 |
4,899 |
4,807 |
- |
4,704 |
| Total Debt |
|
3,244 |
3,247 |
3,191 |
3,143 |
3,093 |
3,043 |
3,019 |
2,995 |
2,849 |
- |
2,751 |
| Total Long-Term Debt |
|
3,125 |
3,097 |
3,066 |
3,002 |
2,997 |
2,940 |
2,911 |
2,820 |
2,720 |
- |
2,621 |
| Net Debt |
|
2,656 |
2,479 |
2,637 |
2,576 |
2,318 |
2,250 |
2,396 |
2,377 |
2,215 |
- |
2,150 |
| Capital Expenditures (CapEx) |
|
14 |
16 |
11 |
12 |
9.40 |
9.30 |
4.60 |
9.30 |
11 |
- |
12 |
| Net Nonoperating Expense (NNE) |
|
23 |
0.00 |
10 |
0.00 |
0.00 |
0.00 |
-0.34 |
-4.81 |
-2.51 |
- |
16 |
| Net Nonoperating Obligations (NNO) |
|
3,244 |
3,247 |
3,191 |
3,143 |
3,093 |
3,043 |
3,019 |
2,995 |
2,849 |
- |
2,751 |
| Total Depreciation and Amortization (D&A) |
|
61 |
65 |
56 |
57 |
53 |
50 |
50 |
50 |
49 |
- |
50 |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
($0.15) |
$0.31 |
($0.13) |
$0.06 |
$0.15 |
$0.49 |
$0.01 |
$0.25 |
$0.22 |
($0.10) |
($0.05) |
| Adjusted Weighted Average Basic Shares Outstanding |
|
227.20M |
226.90M |
227.90M |
229M |
229.30M |
228.90M |
230.40M |
231.40M |
231.50M |
231.20M |
232.80M |
| Adjusted Diluted Earnings per Share |
|
($0.15) |
$0.31 |
($0.13) |
$0.06 |
$0.14 |
$0.49 |
$0.01 |
$0.25 |
$0.22 |
($0.10) |
($0.05) |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
227.20M |
226.90M |
227.90M |
231.50M |
233.40M |
232.80M |
232.30M |
232.40M |
235.90M |
234.70M |
232.80M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
227.25M |
227.33M |
229.05M |
229.25M |
229.49M |
229.73M |
231.29M |
231.53M |
231.60M |
231.82M |
234.30M |
| Normalized Net Operating Profit after Tax (NOPAT) |
|
-4.27 |
84 |
-16 |
25 |
30 |
117 |
7.42 |
52 |
30 |
- |
3.78 |
| Normalized NOPAT Margin |
|
-0.19% |
3.36% |
-0.76% |
1.10% |
1.28% |
4.52% |
0.33% |
2.16% |
1.18% |
- |
0.15% |
| Pre Tax Income Margin |
|
-0.78% |
2.79% |
-1.24% |
0.77% |
2.30% |
5.11% |
0.22% |
3.13% |
1.77% |
- |
-0.39% |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBIT to Interest Expense |
|
-0.17 |
0.00 |
-0.45 |
0.28 |
0.97 |
1.85 |
0.08 |
1.31 |
0.77 |
- |
0.11 |
| NOPAT to Interest Expense |
|
-0.12 |
0.00 |
-0.32 |
0.22 |
0.61 |
2.03 |
0.03 |
0.99 |
0.87 |
- |
0.08 |
| EBIT Less CapEx to Interest Expense |
|
-0.33 |
0.00 |
-0.63 |
0.09 |
0.79 |
1.68 |
-0.01 |
1.14 |
0.58 |
- |
-0.14 |
| NOPAT Less CapEx to Interest Expense |
|
-0.28 |
0.00 |
-0.49 |
0.03 |
0.44 |
1.87 |
-0.06 |
0.81 |
0.69 |
- |
-0.17 |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Dividend Payout Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
| Augmented Payout Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
Key Financial Trends
Cushman & Wakefield (NYSE:CWK) showed a much weaker start to 2026, with profitability under pressure and operating cash flow turning sharply negative. In Q1 2026, the company reported a net loss of $12.6 million, compared with a profit of $51.4 million in Q3 2025 and $1.9 million in Q1 2025. More importantly, operating cash flow was negative $243.5 million, a significant deterioration from $235.5 million of positive operating cash flow in Q3 2025 and negative $162.0 million in Q1 2025.
The quarterly trend suggests a business that remains cyclical and capital-intensive, with earnings that can swing sharply from period to period. Revenue and expense levels were broadly similar in recent quarters, but Q1 2026 was hurt by a large $340.6 million negative change in operating assets and liabilities, which overwhelmed the company’s non-cash earnings add-backs and pushed cash from operations deep into the red.
Balance sheet leverage remains a key watch item. At March 31, 2026, CWK had $2.62 billion of long-term debt and $129.8 million of short-term debt, against $1.95 billion of total common equity. That implies a leveraged capital structure, though the company also held a sizable cash and securities position.
Here are the most important takeaways for retail investors:
- Cash and marketable securities remain substantial. CWK ended Q1 2026 with $600.6 million in cash and $529.2 million in trading account securities, giving it meaningful liquidity.
- Investing cash flow was positive in Q1 2026. The company generated $94.1 million from investing activities, helped by $107.4 million in sales/maturities of investments.
- Revenue remains large and relatively stable quarter to quarter. Q1 2026 total revenue was $2.48 billion, not far from $2.69 billion in Q4 2025 and $2.54 billion in Q3 2025.
- Profitability improved sharply in late 2025 before fading again. The company earned $51.4 million in Q3 2025 and $112.9 million in Q4 2024, showing it can produce solid quarterly earnings in favorable periods.
- Non-interest income is the dominant revenue driver. In Q1 2026, non-interest income was $2.53 billion versus interest expense of $49.2 million, so the business is highly reliant on fee-based and transactional income.
- Depreciation and amortization remain consistent expense items. Q1 2026 depreciation was $25.3 million and amortization was $24.2 million, suggesting ongoing non-cash charges but not a major sudden shift.
- Share count has been fairly steady. Weighted average diluted shares were 232.8 million in Q1 2026 versus 235.9 million in Q3 2025 and 231.4 million in Q2 2025.
- Operating cash flow turned deeply negative in Q1 2026. Net cash from operating activities was negative $243.5 million, a major red flag for near-term cash generation.
- Working capital outflow was the main drag on cash. Changes in operating assets and liabilities used $340.6 million of cash in Q1 2026, far worse than most recent quarters.
- Debt burden remains elevated. Combined short- and long-term debt totaled about $2.75 billion at quarter-end, which limits flexibility if operating performance weakens further.
Bottom line: Cushman & Wakefield still has scale and liquidity, but the latest quarter showed a clear deterioration in cash generation and earnings. Investors should watch for stabilization in working capital, improvement in operating cash flow, and progress on debt reduction before getting more constructive on the stock.
06/01/26 05:27 AM ETAI Generated. May Contain Errors.